Nevertheless, the combined treatment of B02 cells with ZOL+US did induce intracellular accumulation of unprenylated Rap1A in these tumor cells, further demonstrating that US maximized the antitumor effect of ZOL in B02 breast cancer cells in vitro. The gene discussed is RAP1A; the disease is breast carcinoma.